Mortality in HIV+ immunosuppressed adults:intensive screening is equivalent to preventive treatment
The STATIS trial (sponsor Inserm-ANRS) has compared two innovative strategies designed to reduce mortality in severely immunosuppressed HIV-infected adults. Coordinated by Professors François-Xavier B..









